Where our team of guest writers discuss what they think about the current NGP US Issues.
John Lechleiter, newly appointed CEO of Eli Lilly, addresses Lilly’s stance in the industry and reveals the directions in which he’ll be taking the company after stepping into the leadership role on April 1.
Ken Murtha, Regional Vice President Supply for the Americas for AstraZeneca, talks about operations, supply chain management and counterfeit medicines.
Jill Robinson and Mary Ellen Turner of the Global Safety Surveillance, Epidemiology, and Labeling Group at Wyeth Research discuss their approach to risk management.
Acquisitions, mergers, collaborations – everyone’s doing it. Take Bayer, for example, who bought Schering in June 2006 in a deal worth over $27 billion. The intention: to become a global healthcare heavyweight. NGP spoke with Dr. Andreas Busch, Head of Global Drug Discovery, Bayer Schering Pharma, about R&D after the merger.
Customer centric focus: Customer focus has been defined as placing the wants and needs of the customer as the central focus of all business practices within the company. By Performance Validation